Original Research
Accepted on 14 Jul 2025
Clinicopathologic features of superficial esophageal squamous cell carcinoma in different infiltrative growth pattern
Frontiers in Oncology
doi 10.3389/fonc.2025.1512433
31,856 Publications
Volume 15 - 2025
Original Research
Accepted on 14 Jul 2025
Short term outcomes of robotic surgery after neoadjuvant treatment for locally advanced NSCLC: a comparison with the open approach
Frontiers in Oncology
doi 10.3389/fonc.2025.1579943
Original Research
Accepted on 14 Jul 2025
TCR and BCR Repertoire Analysis Reveals Distinct Signatures Between Benign and Malignant Ovarian Tumors
Frontiers in Oncology
doi 10.3389/fonc.2025.1630707
Case Report
Accepted on 14 Jul 2025
Müllerian Papilloma: Two Case Reports of Malignant Transformation and Literature Review
Frontiers in Oncology
doi 10.3389/fonc.2025.1573747
Case Report
Accepted on 14 Jul 2025
Hypercalcemic Small Cell Ovarian Carcinoma in Pregnancy: Diagnostic and Therapeutic Challenges
Frontiers in Oncology
doi 10.3389/fonc.2025.1648580
Original Research
Accepted on 14 Jul 2025
Immunogenic Cell Death-Related Genes as Prognostic Biomarkers and Therapeutic Insights in Uterine Corpus Endometrial Carcinoma: An Integrative Bioinformatics Analysis
Frontiers in Oncology
doi 10.3389/fonc.2025.1588703
Review
Accepted on 14 Jul 2025
cGAS-STING signal status after EGFR-TKIs resistance in Non-Small Cell Lung Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1643349
Brief Research Report
Accepted on 14 Jul 2025
Current practices and challenges in the management of cancer-associated thrombosis: a survey of Italian oncologists
Frontiers in Oncology
doi 10.3389/fonc.2025.1579464
Original Research
Accepted on 14 Jul 2025
Oxidative Stress-Related Genes in Uveal Melanoma: the Roles of CALM1 in Modulating Oxidative Stress, Apoptosis, and Prognostic Significance
Frontiers in Oncology
doi 10.3389/fonc.2025.1618601
Case Report
Accepted on 14 Jul 2025
Case Report: Reactive T-cell Large Granular Lymphocytes in the Bone Marrow of a Patient with Relapsed/Refractory Multiple Myeloma Receiving Teclistamab
Frontiers in Oncology
doi 10.3389/fonc.2025.1630929
Review
Accepted on 14 Jul 2025
Physical Activity and Glioblastoma: A Paradigm Shift in Neuro-Oncology Therapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1638060
Case Report
Accepted on 14 Jul 2025
An Exceptional Oncological Enigma: Primary Renal Ewing Sarcoma in a Clinical Context-A case report
Frontiers in Oncology
doi 10.3389/fonc.2025.1602774
Original Research
Accepted on 14 Jul 2025
The Curative Effect Analysis of Simultaneous U-VATS for Bilateral Multiple Primary Early-Stage Lung Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1639138
Original Research
Accepted on 14 Jul 2025
Clinical study of 99m Tc-Rituximab combined with dyes double tracing for axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1568550
Original Research
Accepted on 14 Jul 2025
A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1573462
Original Research
Accepted on 14 Jul 2025
Individualization of Clinical Target Volume Delineation in Eccentric Nasopharyngeal Carcinoma: A Prospective Comparative Study
Frontiers in Oncology
doi 10.3389/fonc.2025.1587764